122 related articles for article (PubMed ID: 33814542)
1. Evaluation of a Nanoparticle-Based Busulfan Immunoassay for Rapid Analysis on Routine Clinical Analyzers.
Hilaire MR; Gill RV; Courtney JB; Baburina I; Gardiner J; Milone MC; Shaw LM; Meng QH; Salamone SJ
Ther Drug Monit; 2021 Dec; 43(6):766-771. PubMed ID: 33814542
[TBL] [Abstract][Full Text] [Related]
2. Automation in Busulfan Therapeutic Drug Monitoring: Evaluation of an Immunoassay on two Routine Chemistry Analyzers.
Verougstraete N; Stove V; Verstraete AG; Oyaert M
Ther Drug Monit; 2022 Apr; 44(2):335-339. PubMed ID: 34985848
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Busulfan as a Third-Party Immunoassay on a Clinical Chemistry Analyzer.
Zhou JR; To A; Fritz J; Jung B; Yazdanpanah M; Kulasingam V
J Appl Lab Med; 2024 May; 9(3):549-557. PubMed ID: 38332638
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of a nanoparticle-based immunoassay for determining paclitaxel concentrations on routine clinical analyzers.
Cline DJ; Zhang H; Lundell GD; Harney RL; Riaz HK; Jarrah J; Li Y; Miyazaki M; Courtney JB; Baburina I; Salamone SJ
Ther Drug Monit; 2013 Dec; 35(6):809-15. PubMed ID: 24263640
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a liquid chromatography-tandem mass spectrometry assay to quantify plasma busulfan.
French D; Sujishi KK; Long-Boyle JR; Ritchie JC
Ther Drug Monit; 2014 Apr; 36(2):169-74. PubMed ID: 24625541
[TBL] [Abstract][Full Text] [Related]
6. An automated nanoparticle-based homogeneous immunoassay for determining docetaxel concentrations in plasma.
Cline DJ; Zhang H; Lundell GD; Harney RL; Riaz HK; Jarrah J; Li Y; Miyazaki M; Courtney JB; Baburina I; Salamone SJ
Ther Drug Monit; 2013 Dec; 35(6):803-8. PubMed ID: 24263639
[TBL] [Abstract][Full Text] [Related]
7. Rapid Homogeneous Immunoassay to Quantify Gemcitabine in Plasma for Therapeutic Drug Monitoring.
Kozo D; Ross MW; Jarrah J; Barrett M; Harney RL; Courtney JB; Baburina I; Holleran JL; Beumer JH; Peters GJ; Honeywell RJ; Salamone SJ
Ther Drug Monit; 2017 Jun; 39(3):235-242. PubMed ID: 28490046
[TBL] [Abstract][Full Text] [Related]
8. High-Throughput Validated Method for the Quantitation of Busulfan in Plasma Using Ultrafast SPE-MS/MS.
Danso D; Jannetto PJ; Enger R; Langman LJ
Ther Drug Monit; 2015 Jun; 37(3):319-24. PubMed ID: 25970507
[TBL] [Abstract][Full Text] [Related]
9. Quantification of human plasma-busulfan concentration by liquid chromatography-tandem mass spectrometry.
Moon SY; Lim MK; Hong S; Jeon Y; Han M; Song SH; Lim KS; Yu KS; Jang IJ; Lee JW; Kang HJ; Song J
Ann Lab Med; 2014 Jan; 34(1):7-14. PubMed ID: 24422189
[TBL] [Abstract][Full Text] [Related]
10. A Simple and Accurate Liquid Chromatography-Tandem Mass Spectrometry Method for Therapeutic Drug Monitoring of Busulfan in Plasma.
Lee EJ; Park N; Lee SH; Lee W; Kim HS; Chun S; Min WK
Ann Clin Lab Sci; 2019 Mar; 49(2):212-217. PubMed ID: 31028066
[TBL] [Abstract][Full Text] [Related]
11. A Simple Liquid Chromatography Tandem Mass Spectrometry Method for Quantitation of Plasma Busulfan.
Deng S; Kiscoan M; Frazee C; Abdel-Rahman S; Dalal J; Garg U
Methods Mol Biol; 2016; 1383():79-87. PubMed ID: 26660176
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the docetaxel concentration in human plasma measured with liquid chromatography-tandem mass spectrometry (LC-MS/MS) and a nanoparticle immunoassay and clinical applications of that assay.
Geng C; Li P; Chen X; Yuan G; Guo N; Liu H; Zhang R; Guo R
Biosci Trends; 2017 May; 11(2):202-208. PubMed ID: 28420860
[TBL] [Abstract][Full Text] [Related]
13. A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometry.
Ansari M; Uppugunduri CR; Déglon J; Théorêt Y; Versace F; Gumy-Pause F; Ozsahin H; Dayer P; Desmules J; Daali Y
Rapid Commun Mass Spectrom; 2012 Jun; 26(12):1437-46. PubMed ID: 22592987
[TBL] [Abstract][Full Text] [Related]
14. UPLC-Tandem Mass Spectrometry for Quantification of Busulfan in Human Plasma: Application to Therapeutic Drug Monitoring.
Matar KM; Alshemmari SH; Refaat S; Anwar A
Sci Rep; 2020 Jun; 10(1):8913. PubMed ID: 32488110
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Drug Monitoring of Busulfan for the Management of Pediatric Patients: Cross-Validation of Methods and Long-Term Performance.
Choong E; Uppugunduri CRS; Marino D; Kuntzinger M; Doffey-Lazeyras F; Lo Piccolo R; Chalandon Y; Peters C; Daali Y; Ansari M
Ther Drug Monit; 2018 Feb; 40(1):84-92. PubMed ID: 29189665
[TBL] [Abstract][Full Text] [Related]
16. Multicenter evaluation of a novel nanoparticle immunoassay for 5-fluorouracil on the Olympus AU400 analyzer.
Beumer JH; Boisdron-Celle M; Clarke W; Courtney JB; Egorin MJ; Gamelin E; Harney RL; Hammett-Stabler C; Lepp S; Li Y; Lundell GD; McMillin G; Milano G; Salamone SJ
Ther Drug Monit; 2009 Dec; 31(6):688-94. PubMed ID: 19935361
[TBL] [Abstract][Full Text] [Related]
17. A rapid and simple LC-MS/MS method for personalized busulfan dosing in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT).
Xiao Y; Li X; Fu X
Clin Chim Acta; 2018 Apr; 479():190-195. PubMed ID: 29341904
[TBL] [Abstract][Full Text] [Related]
18. Performance characteristics of the ARK diagnostics gabapentin immunoassay.
Juenke JM; Wienhoff KA; Anderson BL; McMillin GA; Johnson-Davis KL
Ther Drug Monit; 2011 Aug; 33(4):398-401. PubMed ID: 21654348
[TBL] [Abstract][Full Text] [Related]
19. Determination of Busulfan and Melphalan in Plasma by Turbulent Flow Chromatography-Tandem Mass Spectrometry.
Schofield RC; Scordo M; Shah G; Carlow DC
Methods Mol Biol; 2024; 2737():141-151. PubMed ID: 38036818
[TBL] [Abstract][Full Text] [Related]
20. Development of a rapid and specific assay for detection of busulfan in human plasma by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.
dos Reis EO; Vianna-Jorge R; Suarez-Kurtz G; Lima EL; Azevedo Dde A
Rapid Commun Mass Spectrom; 2005; 19(12):1666-74. PubMed ID: 15912469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
